Status:
COMPLETED
Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Deep Vein Thrombosis
Pulmonary Embolism
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to learn if apixaban can prevent blood clots in the leg (deep vein Thrombosis \[DVT\]) and lung (pulmonary embolism \[PE\]) that sometimes occur after knee replacement sur...
Eligibility Criteria
Inclusion
- Key
- Men and non-pregnant, non-breastfeeding women
- 18 years or older
- Scheduled for knee replacement surgery
- Key
Exclusion
- hereditary or acquired bleeding disorders
- clotting disorders
- bleeding or high risk for bleeding
- drugs that affect bleeding or coagulation
- need for ongoing parenteral or oral anticoagulation
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
3608 Patients enrolled
Trial Details
Trial ID
NCT00371683
Start Date
November 1 2006
End Date
May 1 2008
Last Update
December 30 2015
Active Locations (107)
Enter a location and click search to find clinical trials sorted by distance.
1
Capstone Clinical Trials, Inc
Birmingham, Alabama, United States, 35205
2
Capstone Clinical Trials, Inc
Birmingham, Alabama, United States, 35209
3
West Alabama Research, Inc.
Tuscaloosa, Alabama, United States, 35406
4
Martin Bowen Hefley Orthopedics
Little Rock, Arkansas, United States, 72205